We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

48 hedge funds and large institutions have $4.25M invested in Cardiff Oncology in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 23 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.1% less ownership

Funds ownership: 0.25% → 0.15% (-0.1%)

23% less funds holding

Funds holding: 62 → 48 (-14)

34% less capital invested

Capital invested by funds: $6.47M → $4.25M (-$2.22M)

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

70% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 23

Holders
48
Holders Change
-14
Holders Change %
-22.58%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
23
Closed
22
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$82K

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$228K
2
Millennium Management
Millennium Management
New York
+$220K
3
ECM
Element Capital Management
New York
+$118K
4
LP
LMR Partners
United Kingdom
+$107K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$76K

Top Sellers

1
BlackRock
BlackRock
New York
-$1.13M
2
State Street
State Street
Massachusetts
-$367K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$262K
4
Northern Trust
Northern Trust
Illinois
-$233K
5
VKH
Virtu KCG Holdings
New York
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
26
Cambridge Investment Research Advisors
Iowa
$28K -$2.19K -34 -10%
Bank of Montreal
27
Bank of Montreal
Ontario, Canada
$28K +$2.19K +34 +12%
VKH
28
Virtu KCG Holdings
New York
$14K -$178K -2,768 -95%
UBS Group
29
UBS Group
Switzerland
$14K -$2.19K -34 -18%
Jane Street
30
Jane Street
New York
$14K +$9.66K +150 New
CS
31
Credit Suisse
Switzerland
$14K +$10.1K +157 New
Bank of America
32
Bank of America
North Carolina
$9K -$64 -1 -1%
Creative Planning
33
Creative Planning
Kansas
$9K – – –
TRCT
34
Tower Research Capital (TRC)
New York
$7K -$34.8K -540 -88%
IA
35
IFP Advisors
Florida
$4K – – –
Northwestern Mutual Wealth Management
36
Northwestern Mutual Wealth Management
Wisconsin
$4K – – –
BWA
37
BDO Wealth Advisors
Florida
$4K +$2.71K +42 New
IP
38
Intellectus Partners
California
$3K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K -$64 -1 -6%
MAM
40
Meeder Asset Management
Ohio
$2K +$451 +7 +47%
Wells Fargo
41
Wells Fargo
California
$1K -$14.9K -232 -95%
Simplex Trading
42
Simplex Trading
Illinois
$1K -$193 -3 -15%
Carson Wealth (CWM LLC)
43
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
CG
44
Cutler Group
California
$1K +$966 +15 New
CFA
45
Carroll Financial Associates
North Carolina
$1K +$1.35K +21 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$26 -$129 -2 Closed
TSS
47
Two Sigma Securities
New York
– -$139K -1,674 Closed
TCIM
48
TIAA CREF Investment Management
New York
– -$88K -1,060 Closed
TA
49
Teachers Advisors
New York
– -$71K -859 Closed
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
– -$67K -804 Closed
1
2
3

CRDF Hedge Fund Activity: Q2 2017 in Review

48 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2017, worth a combined $4.25M — down 34% from $6.47M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of CRDF and 9 opened new positions — a net loss of 13 holders — while 23 trimmed existing stakes and 7 added.

The largest buyer was Goldman Sachs, adding an estimated $228K. The largest seller was BlackRock, cutting an estimated $1.13M.

  • 48 institutional investors held Cardiff Oncology (CRDF) as of Q2 2017, down from 62 in Q1 2017.
  • Funds reported $4.25M of Cardiff Oncology stock for Q2 2017, down 34% quarter-over-quarter.
  • 9 funds opened new Cardiff Oncology positions in Q2 2017 and 22 closed out, a net change of -13 holders.
  • The largest Cardiff Oncology buyer in Q2 2017 was Goldman Sachs, an estimated $228K added.
  • The largest Cardiff Oncology seller in Q2 2017 was BlackRock, an estimated $1.13M sold.

Based on aggregated 13F filings for Q2 2017.